Page results
-
Mouth cancer is where a tumour develops on the surface of the tongue, lips, gums or jaws.
-
This page explains what you can expect before, during and after your treatment in chemotherapy daycare.
-
UCLH is an established tertiary referral colorectal unit. We offer comprehensive surgical and medical treatment for anal, colon and rectal cancers.
-
This information is for patients who are having radiotherapy for a base of skull tumour. It explains what the treatment involves, describes side-effects you may experience during and after treatment, and how best to cope with them.
-
This page explains what autologous stem cell transplant is and includes information about our stem cell transplant service and process, the care patients will receive and what to expect after the transplant.
-
The aim of this page is to give information about how we induce labours.
-
This booklet explains what stem cells are and how they are collected from your blood. It includes information about what happens before, during and after the collection, and how the cells are stored.
-
Information for patients about the RLHIM's Psychological Therapy Services
-
Cerebral palsy (CP) is a permanent disorder affecting movement in different parts of the body often accompanied by disturbances of sensation, cognition, communication, perception, behaviour and musculoskeletal problems.
-
This page provides information about the support you can have with some of your concerns while living with myeloma.
File results
-
FOI/2022/0047 - Waiting for non-urgent hospital treatment
-
FOI/2022/0048 - Cancer deaths in relation to Covid-19
-
FOI/2022/0050 - Patients on a waiting list for Tier 4 weight management services
-
FOI/2022/0052 - Makes/ models of plasma thawer used in Pathology/ transfusion
-
FOI/2022/0062 - Vehicle fleet information and governance
-
FOI/2022/0064 - Neonatal visiting policy/ visitation rights
-
FOI/2022/0068 - Staff and covid vaccinations
-
FOI/2022/0070 - Viscosupplementation use and spend
-
FOI/2022/0071 - Sodium Hyaluronate eye drops
-
FOI/2022/0076 - Private patient third party involvement